Role of magnetic susceptibility-weighted imaging in characterization of cerebral microbleeds in acute ischemic stroke Egyptian obese patients

Abou Elmaaty, Ali Ahmed; Zarad, Carmen Ali

doi:10.1186/s41983-020-00202-2

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 3 Univariate analysis of predictors of CMBs

From: Role of magnetic susceptibility-weighted imaging in characterization of cerebral microbleeds in acute ischemic stroke Egyptian obese patients

Predictor	No microbleeds (n = 84)	Microbleeds (n = 36)	Test of significance		Simple logistic regression
Predictor	No microbleeds (n = 84)	Microbleeds (n = 36)	Statistic	P1	Crude odds ratio	P2
Sex
Female	45 (53.6%)	21 (58.3%)	χ² = 0.231	0.631	R	0.631
Male	39 (46.4%)	15 (41.7%)	χ² = 0.231	0.631	0.824	0.631
BMI
Overweight	36 (42.9%)	7 (19.4%)	χ² = 6.008	0.014	R	0.017
Obese	48 (57.1%)	29 (80.6%)	χ² = 6.008	0.014	3.107	0.017
Grade I	37 (44.0%)	16 (44.4%)	FET	0.010	2.223	0.002
Grade II	09 (10.7%)	09 (25.0%)
Grade III	02 (2.4%)	04 (11.1%)
Hypertension
No	52 (61.9%)	6 (16.7%)	χ² = 20.652	< 0.001	R	< 0.001
Yes	32 (38.1%)	30 (83.3%)	χ² = 20.652	< 0.001	8.125	< 0.001
DM
No	49 (58.3%)	23 (63.9%)	χ² = 0.324	0.569	R	0.570
Yes	35 (41.7%)	13 (36.1%)	χ² = 0.324	0.569	0.791	0.570
Dyslipidemia
No	53 (63.1%)	13 (36.1%)	χ² = 7.414	0.006	R	0.008
Yes	31 (36.9%)	23 (63.9%)	χ² = 7.414	0.006	3.025	0.008
AF
No	69 (82.1%)	34 (94.4%)	χ² = 3.136	0.077	R	0.094
Yes	15 (17.9%)	2 (5.6%)	χ² = 3.136	0.077	0.271	0.094
IHD
No	53 (63.1%)	14 (38.9%)	χ² = 5.988	0.014	R	0.016
Yes	31 (36.9%)	22 (61.1%)	χ² = 5.988	0.014	2.687	0.016
On antiplatelet drugs
No	54 (64.3%)	15 (41.7%)	χ² = 5.276	0.022	R	0.023
Yes	30 (35.7%)	21 (58.3%)	χ² = 5.276	0.022	2.520	0.023
On anticoagulant drugs
No	69 (82.1%)	34 (94.4%)	χ² = 3.136	0.077	R	0.094
Yes	15 (17.9%)	2 (5.6%)	χ² = 3.136	0.077	0.271	0.094
Brain MRI
LVDs	74 (88.1%)	14 (38.9%)	χ² = 31.201	< 0.001	R	< 0.001
SVDs	10 (11.9%)	22 (61.1%)	χ² = 31.201	< 0.001	11.629	< 0.001
Age (years)	68.5 (63–75)	68 (65.3–73.8)	Z = − 0.077	0.938	0.988	0.689
BMI (kg/m²)	30.6 (28.7–33.97)	33.5 (30.9–37.2)	Z = − 3.196	0.001	1.195	0.001
Serum TC (mg/dl)	179.5 (144.5–227)	233 (175–251)	Z = − 3.064	0.002	1.013	0.002
Serum TG (mg/dl)	129 (109–161)	146.5 (110.5–169.5)	Z = − 0.465	0.642	1.000	0.918
Serum HDL-C (mg/dl)	43 (35.3–51.8)	44.5 (41.3–59)	Z = − 1.750	0.080	1.029	0.037
Serum LDL-C (mg/dl)	96 (68–137.8)	141 (69–175.8)	Z = − 3.112	0.002	1.014	0.004

R reference category, COR crude odds ratio, P1, P2 simple logistic regression, DM diabetes mellitus, AF atrial fibrillation, IHD ischemic heart disease, LVDs large vessel diseases, SVDs small vessel diseases, BMI body mass index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-C, LDI-C low-density lipoprotein-C

Back to article page